Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-04-22
1994-03-08
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514438, 546329, 546334, 546337, 548202, 548204, 548205, 5483355, 5483751, 548561, 549 74, 549 75, 549 77, 549492, 549493, 540567, C07D 3320, C07D21338, A61K 3144, A61K 3138
Patent
active
052927601
ABSTRACT:
Novel 4,5-dihydro-4-heteroaryl-3H-1,3-benzodiazepines, intermediates, processes for the preparation thereof, and methods for treating depression, inhibiting convulsions and treating anxiety utilizing compounds and compositions thereof are disclosed.
REFERENCES:
P. K. Kadaba, Drugs of the Future, 15, pp. 1013-1024, 1990.
J. B. Uney et al., Scrip Reports Neurodegeneration and Neuroprotection, "Molecular and Cellular Events Accompanying Nerve Cell Death", pp. 35-40, 1990.
SCRIP Reports, Neurodegeneration and Neuroprotection, M. V. Sonfroniew et al., "Experimental Models of Neuronal Degeneration and Alzheimer's Disease", pp. 10-16 (1990).
D. M. Barnes on Science, 235, 632 (1987).
Brucato Salvatore M.
Martin Lawrence L.
Payack Joseph F.
Gerstl Robert
Hoechst-Roussel Pharmaceuticals Inc.
Korsen Elliott
LandOfFree
4-heteroaryl-1,3-benzodiazepines and 2-substituted-.alpha.-(hete does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-heteroaryl-1,3-benzodiazepines and 2-substituted-.alpha.-(hete, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-heteroaryl-1,3-benzodiazepines and 2-substituted-.alpha.-(hete will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-153699